Microbiome Therapeutics & Diagnostics Market Report 2018-2023

Market Research Report

Global Microbiome Therapeutics & Diagnostics Market Analysis & Forecast to 2023 Report offered by DecisionDatabases.com gives a market overview of the Microbiome Therapeutics & Diagnostics industry.

This report provides a comprehensive overview of the size of the microbiome therapeutic and diagnostic market, segmentation of the market (Gastrointestinal, Metabolic, Cancer, Neurological, Autoimmune, Skin), key players and the potential of therapies that are in clinical trials.

The global microbiome therapeutic and diagnostic market is worth $1.13 billion in 2018 and will grow at a CAGR of 19.03% over five years to $2.7 billion in 2023. The majority of the market will be dominated by microbiome based therapeutics, with an estimate of x%, compared to x% in microbiome diagnostics. This report describes the evolution of such a prospective market in eight chapters supported by over 82 tables and figures in 165 pages.

Browse the complete report and table of contents @ https://www.decisiondatabases.com/ip/31567-microbiome-therapeutics-diagnostics-market-analysis-report

  • An overview of the human microbiome space that includes how the market is sub-divided into therapeutics (prebiotics, probiotics, fecal microbiota transplantation, small molecules) and diagnostics.
    • Global microbiome market, global breakdown, application breakdown and leading market players
    • Detailed account of the microbiome industry market by geography, indication and company profiles
    • Profiles, pipeline products, financial analysis and business strategy of the major companies in this space
    • Focus on current trends, business environment, pipeline products, clinical trials, and future market forecast for microbiome therapeutics and diagnostics
    • Insight into the challenges faced by stakeholders
    • Insight into the biobanking industry globally and its impact on the overall market
    • Description and data for the prevalence of disease types that are addressed by harnessing the human microbiota
    • Financial market forecast through 2023 with CAGR values of all market segments outlined in the objective
    • SWOT analysis of the global market
    • Geographical analysis and challenges within key topographies including North America, Europe, Asia/Pacific, Middle East/Africa, ROW

Competitive Landscape

The microbiome field is highly competitive, especially within the inflammatory bowel disease and Clostridium difficile infection therapeutic markets.  A wide range of big pharma, biotech, early-stage companies, academic institutions, government agencies and other public and private research organizations are involved in this space.  The main therapeutic competitors within the microbiome industry are as follows:
• Johnson & Johnson
• Novartis International
• Abbvie
• Takeda
• Merck & Co.,
• Bristol Myers Squibb
• Pfizer
• Seres Therapeutics
• Vedanta Biosciences
• Finch Therapeutics
• Enterome Bioscience
• Second Genome

Download Free Sample Report of Global Microbiome Therapeutics & Diagnostics Market @

There are 8 Chapters to deeply display the Global Microbiome Therapeutics & Diagnostics market.

Chapter 1 Executive Summary

Chapter 2 Microbiome Overview

Chapter 3 Human Therapeutic and Diagnostic Pipeline Analysis

Chapter 4 Market Analysis & Forecast to 2023

Chapter 5 Market Drivers, Trends & SWOT Analysis

Chapter 6 Investment and Market Deals

Chapter 7 Venture Capital and The Microbiome

Chapter 8 Major Players and Company Profiles

Purchase the complete Global Microbiome Therapeutics & Diagnostics Market Research Report @

Other Reports by DecisionDatabases.com:

Global Human Microbiome Market by Manufacturers, Countries, Type and Application, Forecast to 2023 @ https://www.decisiondatabases.com/ip/13308-human-microbiome-industry-market-report

Global Regenerative Medicine Market Analysis & Forecast to 2022; Stem Cells, Tissue Engineering, BioBanking & CAR-T Industries @ https://www.decisiondatabases.com/ip/16872-regenerative-medicine-market-analysis-report

DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.

Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.

For more details:
E Mail: sales@decisiondatabases.com
Phone: +91 99 28 237112
Web: www.decisiondatabases.com/